Behavioral and neurobiological consequences of prolonged glucocorticoid exposure in rats: Relevance to depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 5, 2010, Pages 777-790

  Sterner, Erin Y ^a   Kalynchuk, Lisa E ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Animal model; Corticosterone; Depression; Hippocampus; Rat; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; REELIN;

ACUTE STRESS; AMYGDALOID NUCLEUS; ANHEDONIA; ANXIETY; CHRONIC STRESS; COGNITIVE DEFECT; CONDITIONING; DECLARATIVE MEMORY; DEPRESSION; DISEASE MODEL; FORCED SWIMMING TEST; HELPLESSNESS; HIPPOCAMPUS; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MENTAL STRESS; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NONHUMAN; PHYSICAL STRESS; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; REFERENCE MEMORY; REVIEW; SPATIAL MEMORY; THALAMUS MIDLINE NUCLEUS; VERBAL MEMORY; WORKING MEMORY;

ADULT; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; COGNITION; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; PITUITARY-ADRENAL SYSTEM; RATS;

EID: 77953692243     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.03.005     Document Type: Review

References (229)

1. Ago Y., Arikawa S., Yata M., Yano K., Abe M., Takuma K., et al. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Neuropharmacology 2008, 55:1355-1363.
2. Alahmed S., Herbert J. Strain differences in proliferation of progenitor cells in the dentate gyrus of the adult rat and the response to fluoxetine are dependent on corticosterone. Neuroscience 2008, 157:677-682.
3. Alfonso J., Aguero F., Sanchez D.O., Flugge G., Fuchs E., Frasch A.C., et al. Gene expression analysis in the hippocampal formation of tree shrews chronically treated with cortisol. J Neurosci Res 2004, 78:702-710.
4. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia 2000, 31:219-231.
5. Diagnostic and statistical manual of mental disorders 2001, American Psychiatric Association, American Psychiatric Association, Washington, Text revision (DSM-IV-TR). 4th ed.
6. Amsterdam J.D., Maislin G., Winokur A., Kling M., Gold P. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers. Arch Gen Psychiatry 1987, 44:775-781.
7. Amsterdam J.D., Maislin G., Winokur A., Berwish N., Kling M., Gold P. The oCRH stimulation test before and after clinical recovery from depression. J Affect Disord 1988, 14:213-222.
8. Arbel I., Kadar T., Silbermann M., Levy A. The effects of long-term corticosterone administration on hippocampal morphology and cognitive performance of middle-aged rats. Brain Res 1994, 657:227-235.
9. Armario A., Gavalda A., Marti O. Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate. Eur J Pharmacol 1988, 158:207-212.
10. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001, 178:200-206.
11. Bardgett M.E., Taylor G.T., Csernansky J.G., Newcomer J.W., Nock B. Chronic corticosterone treatment impairs spontaneous alternation behavior in rats. Behav Neural Biol 1994, 61:186-190.
12. Barr A.M., Brotto L.A., Phillips A.G. Chronic corticosterone enhances the rewarding effect of hypothalamic self-stimulation in rats. Brain Res 2000, 875:196-201.
13. Beck K.D., Luine V.N. Sex differences in behavioral and neurochemical profiles after chronic stress: role of housing conditions. Physiol Behav 2002, 75:661-673.
14. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7:137-151.
15. Bodnoff S.R., Humphreys A.G., Lehman J.C., Diamond D.M., Rose G.M., Meaney M.J. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci 1995, 15:61-69.
16. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology (Berl) 1988, 94:147-160.
17. Bourdeau I., Bard C., Noel B., Leclerc I., Cordeau M.P., Belair M., et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002, 87:1949-1954.
18. Bowman R.E., Beck K.D., Luine V.N. Chronic stress effects on memory: sex differences in performance and monoaminergic activity. Horm Behav 2003, 43:48-59.
19. Bravo J.A., az-Veliz G., Mora S., Ulloa J.L., Berthoud V.M., Morales P., et al. Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behav Pharmacol 2009, 20:273-285.
20. Bremner J.D., Scott T.M., Delaney R.C., Southwick S.M., Mason J.W., Johnson D.R., et al. Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry 1993, 150:1015-1019.
21. Breslau N., Schultz L., Peterson E. Sex differences in depression: a role for preexisting anxiety. Psychiatry Res 1995, 58:1-12.
22. Brummelte S., Pawluski J.L., Galea L.A. High post-partum levels of corticosterone given to dams influence postnatal hippocampal cell proliferation and behavior of offspring: a model of post-partum stress and possible depression. Horm Behav 2006, 50:370-382.
23. Buchanan T.W., Lovallo W.R. Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology 2001, 26:307-317.
24. Buchwald A.M., Rudick-Davis D. The symptoms of major depression. J Abnorm Psychol 1993, 102:197-205.
25. Bush V.L., Middlemiss D.N., Marsden C.A., Fone K.C. Implantation of a slow release corticosterone pellet induces long-term alterations in serotonergic neurochemistry in the rat brain. J Neuroendocrinol 2003, 15:607-613.
26. Caetano S.C., Hatch J.P., Brambilla P., Sassi R.B., Nicoletti M., Mallinger A.G., et al. Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res 2004, 132:141-147.
27. Castaneda A.E., Tuulio-Henriksson A., Marttunen M., Suvisaari J., Lonnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 2008, 106:1-27.
28. Cereseto M., Reines A., Ferrero A., Sifonios L., Rubio M., Wikinski S. Chronic treatment with high doses of corticosterone decreases cytoskeletal proteins in the rat hippocampus. Eur J Neurosci 2006, 24:3354-3364.
29. Cerqueira J.J., Pego J.M., Taipa R., Bessa J.M., Almeida O.F., Sousa N. Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J Neurosci 2005, 25:7792-7800.
30. Cerqueira J.J., Taipa R., Uylings H.B., Almeida O.F., Sousa N. Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens. Cereb Cortex 2007, 17:1998-2006.
31. Checkley S. Neuroendocrine mechanisms and the precipitation of depression by life events. Br J Psychiatry 1992, 7-17. Suppl.
32. Checkley S. The neuroendocrinology of depression and chronic stress. Br Med Bull 1996, 52:597-617.
33. Clark A.S., Mitre M.C., Brinck-Johnsen T. Anabolic-androgenic steroid and adrenal steroid effects on hippocampal plasticity. Brain Res 1995, 679:64-71.
34. Coburn-Litvak P.S., Pothakos K., Tata D.A., McCloskey D.P., Anderson B.J. Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats. Neurobiol Learn Mem 2003, 80:11-23.
35. Conrad C.D., Galea L.A., Kuroda Y., McEwen B.S. Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 1996, 110:1321-1334.
36. Conrad C.D., LeDoux J.E., Magarinos A.M., McEwen B.S. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci 1999, 113:902-913.
37. Conrad C.D., Grote K.A., Hobbs R.J., Ferayorni A. Sex differences in spatial and non-spatial Y-maze performance after chronic stress. Neurobiol Learn Mem 2003, 79:32-40.
38. Conrad C.D., MacMillan D.D., Tsekhanov S., Wright R.L., Baran S.E., Fuchs R.A. Influence of chronic corticosterone and glucocorticoid receptor antagonism in the amygdala on fear conditioning. Neurobiol Learn Mem 2004, 81:185-199.
39. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 2005, 29:547-569.
40. Dachir S., Kadar T., Robinzon B., Levy A. Cognitive deficits induced in young rats by long-term corticosterone administration. Behav Neural Biol 1993, 60:103-109.
41. Dachir S., Schmidt B., Levy A. Effects of metrifonate on radial arm maze acquisition in middle-aged rats. Brain Res 1997, 777:251-254.
42. D'Amato F.R., Rizzi R., Moles A. A model of social stress in dominant mice: effects on sociosexual behaviour. Physiol Behav 2001, 73:421-426.
43. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
44. de Kloet E.R., Vreugdenhil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998, 19:269-301.
45. Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 1998, 352:1754-1755.
46. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry 2000, 48:813-829.
47. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001, 11:240-249.
48. Duman R.S. Pathophysiology of depression: the concept of synaptic plasticity. Eur Psychiatry 2002, 17(Suppl 3):306-310.
49. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000, 48:732-739.
50. Dunn A.J., Swiergiel A.H. Effects of acute and chronic stressors and CRF in rat and mouse tests for depression. Ann N Y Acad Sci 2008, 1148:118-126.
51. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
52. Dwivedi Y., Rizavi H.S., Pandey G.N. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 2006, 139:1017-1029.
53. Endo Y., Nishimura J.I., Kimura F. Impairment of maze learning in rats following long-term glucocorticoid treatments. Neurosci Lett 1996, 203:199-202.
54. Fatemi S.H., Earle J.A., McMenomy T. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000, 5:654-663. 571.
55. Fatemi S.H., Reutiman T.J., Folsom T.D. Chronic psychotropic drug treatment causes differential expression of reelin signaling system in frontal cortex of rats. Schizophr Res 2009, 111:138-152.
56. Feldman S., Conforti N., Weidenfeld J. Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli. Neurosci Biobehav Rev 1995, 19:235-240.
57. Fleming S.K., Blasey C., Schatzberg A.F. Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis. J Psychiatr Res 2004, 38:27-35.
58. Forster E., Jossin Y., Zhao S., Chai X., Frotscher M., Goffinet A.M. Recent progress in understanding the role of reelin in radial neuronal migration, with specific emphasis on the dentate gyrus. Eur J Neurosci 2006, 23:901-909.
59. Frodl T., Meisenzahl E.M., Zill P., Baghai T., Rujescu D., Leinsinger G., et al. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 2004, 61:177-183.
60. Frodl T., Schaub A., Banac S., Charypar M., Jager M., Kummler P., et al. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci 2006, 31:316-323.
61. Fuchs E. Neurogenesis in the adult brain: is there an association with mental disorders?. Eur Arch Psychiatry Clin Neurosci 2007, 257:247-249.
62. Fuchs E., Gould E. Mini-review: in vivo neurogenesis in the adult brain: regulation and functional implications. Eur J Neurosci 2000, 12:2211-2214.
63. Galea L.A., McEwen B.S., Tanapat P., Deak T., Spencer R.L., Dhabhar F.S. Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress. Neuroscience 1997, 81:689-697.
64. Gerken A., Holsboer F. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol. Psychoneuroendocrinology 1986, 11:185-194.
65. Gold P.W., Loriaux D.L., Roy A., Kling M.A., Calabrese J.R., Kellner C.H., et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med 1986, 314:1329-1335.
66. Gong C., Wang T.W., Huang H.S., Parent J.M. Reelin regulates neuronal progenitor migration in intact and epileptic hippocampus. J Neurosci 2007, 27:1803-1811.
67. Gorzalka B.B., Hanson L.A. Sexual behavior and wet dog shakes in the male rat: regulation by corticosterone. Behav Brain Res 1998, 97:143-151.
68. Gorzalka B.B., Brotto L.A., Hong J.J. Corticosterone regulation of 5-HT2A receptor-mediated behaviors: attenuation by melatonin. Physiol Behav 1999, 67:439-442.
69. Gorzalka B.B., Hanson L.A., Hong J.J. Ketanserin attenuates the behavioural effects of corticosterone: implications for 5-HT(2A) receptor regulation. Eur J Pharmacol 2001, 428:235-240.
70. Gorzalka B., Hanson L., Harrington J., Killam S., Campbell-Meiklejohn D. Conditioned taste aversion: modulation by 5-HT receptor activity and corticosterone. Eur J Pharmacol 2003, 471:129-134.
71. Gourley S.L., Kiraly D.D., Howell J.L., Olausson P., Taylor J.R. Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol Psychiatry 2008, 64:884-890.
72. Gourley S.L., Wu F.J., Kiraly D.D., Ploski J.E., Kedves A.T., Duman R.S., et al. Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry 2008, 63:353-359.
73. Gourley S.L., Kedves A.T., Olausson P., Taylor J.R. A history of corticosterone exposure regulates fear extinction and cortical NR2B, GluR2/3, and BDNF. Neuropsychopharmacology 2009, 34:707-716.
74. Greden J.F., Gardner R., King D., Grunhaus L., Carroll B.J., Kronfol Z. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 1983, 40:493-500.
75. Gregus A., Wintink A.J., Davis A.C., Kalynchuk L.E. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res 2005, 156:105-114.
76. Grissom N., Iyer V., Vining C., Bhatnagar S. The physical context of previous stress exposure modifies hypothalamic-pituitary-adrenal responses to a subsequent homotypic stress. Horm Behav 2007, 51:95-103.
77. Hanson L.A., Gorzalka B.B. The influence of corticosterone on serotonergic stereotypy and sexual behavior in the female rat. Behav Brain Res 1999, 104:27-35.
78. He W.B., Zhang J.L., Hu J.F., Zhang Y., Machida T., Chen N.H. Effects of glucocorticoids on age-related impairments of hippocampal structure and function in mice. Cell Mol Neurobiol 2008, 28:277-291.
79. Hebda-Bauer E.K., Morano M.I., Therrien B. Aging and corticosterone injections affect spatial learning in Fischer-344×Brown Norway rats. Brain Res 1999, 827:93-103.
80. Heinz E.R., Martinez J., Haenggeli A. Reversibility of cerebral atrophy in anorexia nervosa and Cushing's syndrome. J Comput Assist Tomogr 1977, 1:415-418.
81. Hellesten J., Wennstrom M., Mohapel P., Ekdahl C.T., Bengzo J., Tingstrom A. Electroconvulsive seizures increase hippocampal neurogenesis after chronic corticosterone treatment. Eur J Neurosci 2002, 16:283-290.
82. Henningsen K., Andreasen J.T., Bouzinova E.V., Jayatissa M.N., Jensen M.S., Redrobe J.P., et al. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav Brain Res 2009, 198:136-141.
83. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 1997, 20:78-84.
84. Herman J.P., Adams D., Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995, 61:180-190.
85. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 2003, 24:151-180.
86. Herman J.P., Ostrander M.M., Mueller N.K., Figueiredo H. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1201-1213.
87. Herrmann M., Henneicke H., Street J., Modzelewski J., Kalak R., Buttgereit F., et al. The challenge of continuous exogenous glucocorticoid administration in mice. Steroids 2009, 74:245-249.
88. Hill M.N., Brotto L.A., Lee T.T., Gorzalka B.B. Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:905-911.
89. Hirschfeld R.M. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry 2001, 3:244-254.
90. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J Affect Disord 2001, 62:77-91.
91. Holsboer F., Liebl R., Hofschuster E. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. J Affect Disord 1982, 4:93-101.
92. Holsboer F., Von Bardeleben U., Gerken A., Stalla G.K., Müller O.A. Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 1984, 311:1127.
93. Huang G.J., Herbert J. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biol Psychiatry 2006, 59:619-624.
94. Jacobs B.L., Praag H., Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000, 5:262-269.
95. Jacobsen J.P., Mork A. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res 2006, 1110:221-225.
96. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991, 12:118-134.
97. Jaracz J. The anatomy of depression in light of evidence from neuroimaging studies. Psychiatr Pol 2008, 42:875-888.
98. Johnson S.A., Fournier N.M., Kalynchuk L.E. Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behav Brain Res 2006, 168:280-288.
99. Joo Y., Choi K.M., Lee Y.H., Kim G., Lee D.H., Roh G.S., et al. Chronic immobilization stress induces anxiety- and depression-like behaviors and decreases transthyretin in the mouse cortex. Neurosci Lett 2009, 461:121-125.
100. Kalia M. Neurobiological basis of depression: an update. Metabolism 2005, 54:24-27.
101. Kalynchuk L.E., Gregus A., Boudreau D., Perrot-Sinal T.S. Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats. Behav Neurosci 2004, 118:1365-1377.
102. Kandel E.R. The molecular biology of memory storage: a dialog between genes and synapses. Biosci Rep 2001, 21:565-611.
103. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002, 109:143-148.
104. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 2005, 57:1068-1072.
105. Karishma K.K., Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 2002, 16:445-453.
106. Kessing L.V., Agerbo E., Mortensen P.B. Does the impact of major stressful life events on the risk of developing depression change throughout life?. Psychol Med 2003, 33:1177-1184.
107. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-19.
108. Kessler R.C., Nelson C.B., McGonagle K.A., Liu J., Swartz M., Blazer D.G. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry 1996, 17-30. Suppl.
109. Kim K.S., Han P.L. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J Neurosci Res 2006, 83:497-507.
110. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004, 9:609-620. 544.
111. Konarski J.Z., McIntyre R.S., Kennedy S.H., Rafi-Tari S., Soczynska J.K., Ketter T.A. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 2008, 10:1-37.
112. Laakmann G., Hennig J., Baghai T., Schule C. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients. Ann N Y Acad Sci 2004, 1032:279-282.
113. Lee B., Shim I., Lee H.J., Yang Y., Hahm D.H. Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats. Neurosci Lett 2009, 453:151-156.
114. Lorenzetti V., Allen N.B., Fornito A., Yucel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord 2009, 117:1-17.
115. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997, 8:523-532.
116. Luine V., Villegas M., Martinez C., McEwen B.S. Repeated stress causes reversible impairments of spatial memory performance. Brain Res 1994, 639:167-170.
117. Luine V., Martinez C., Villegas M., Magarinos A.M., McEwen B.S. Restraint stress reversibly enhances spatial memory performance. Physiol Behav 1996, 59:27-32.
118. Lupien S.J., McEwen B.S. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev 1997, 24:1-27.
119. Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 2009, 10:434-445.
120. Lussier A.L., Caruncho H.J., Kalynchuk L.E. Repeated exposure to corticosterone, but not restraint, decreases the number of reelin-positive cells in the adult rat hippocampus. Neurosci Lett 2009, 460:170-174.
121. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003, 100:1387-1392.
122. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 1995, 69:83-88.
123. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995, 69:89-98.
124. Magarinos A.M., Orchinik M., McEwen B.S. Morphological changes in the hippocampal CA3 region induced by non-invasive glucocorticoid administration: a paradox. Brain Res 1998, 809:314-318.
125. Magarinos A.M., Deslandes A., McEwen B.S. Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol 1999, 371:113-122.
126. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
127. Marks W., Fournier N.M., Kalynchuk L.E. Repeated exposure to corticosterone increases depression-like behavior in two different versions of the forced swim test without altering nonspecific locomotor activity or muscle strength. Physiol Behav 2009, 98:67-72.
128. Mayer J.L., Klumpers L., Maslam S., de Kloet E.R., Joels M., Lucassen P.J. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. J Neuroendocrinol 2006, 18:629-631.
129. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J Med 1998, 338:171-179.
130. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci 1999, 22:105-122.
131. McEwen B.S. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000, 22:108-124.
132. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000, 886:172-189.
133. McEwen B.S. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005, 54:20-23.
134. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007, 87:873-904.
135. McKinney W.T., Bunney W.E. Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry 1969, 21:240-248.
136. McLay R.N., Freeman S.M., Zadina J.E. Chronic corticosterone impairs memory performance in the Barnes maze. Physiol Behav 1998, 63:933-937.
137. Meijer O.C., Van Oosten R.V., de Kloet E.R. Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: implication for the pathogenesis of depression. Neuroscience 1997, 80:419-426.
138. Miller M.M., Antecka E., Sapolsky R. Short term effects of glucocorticoids upon hippocampal ultrastructure. Exp Brain Res 1989, 77:309-314.
139. Mineka S., Watson D., Clark L.A. Comorbidity of anxiety and unipolar mood disorders. Annu Rev Psychol 1998, 49:377-412.
140. Mitra R., Sapolsky R.M. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc Natl Acad Sci USA 2008, 105:5573-5578.
141. Muller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J., Holsboer F., Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 2001, 14:1603-1612.
142. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 2008, 583:115-127.
143. Myers B., Greenwood-Van Meerveld B. Corticosteroid-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1622-G1629.
144. Nacher J., Pham K., Gil-Fernandez V., McEwen B.S. Chronic restraint stress and chronic corticosterone treatment modulate differentially the expression of molecules related to structural plasticity in the adult rat piriform cortex. Neuroscience 2004, 126:503-509.
145. Nakagawa S., Kim J.E., Lee R., Chen J., Fujioka T., Malberg J., et al. Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci 2002, 22:9868-9876.
146. Nakagawa S., Kim J.E., Lee R., Malberg J.E., Chen J., Steffen C., et al. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci 2002, 22:3673-3682.
147. Nemeroff C.B. The neurobiology of depression. Sci Am 1998, 278:42-49.
148. Nestler E.J., Barrot M., Dileone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
149. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., et al. Preclinical models: status of basic research in depression. Biol Psychiatry 2002, 52:503-528.
150. Newcomer J.W., Selke G., Melson A.K., Hershey T., Craft S., Richards K., et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999, 56:527-533.
151. Newport D.J., Stowe Z.N., Nemeroff C.B. Parental depression: animal models of an adverse life event. Am J Psychiatry 2002, 159:1265-1283.
152. Nitta A., Fukumitsu H., Kataoka H., Nomoto H., Furukawa S. Administration of corticosterone alters intracellular localization of brain-derived neurotrophic factor-like immunoreactivity in the rat brain. Neurosci Lett 1997, 226:115-118.
153. Niu S., Yabut O., D'Arcangelo G. The reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J Neurosci 2008, 28:10339-10348.
154. O'Dwyer A.M., Lightman S.L., Marks M.N., Checkley S.A. Treatment of major depression with metyrapone and hydrocortisone. J Affect Disord 1995, 33:123-128.
155. Pariante C.M. Depression, stress and the adrenal axis. J Neuroendocrinol 2003, 15:811-812.
156. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001, 49:391-404.
157. Pariante C.M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A.H., et al. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol 2001, 134:1335-1343.
158. Pariante C.M., Hye A., Williamson R., Makoff A., Lovestone S., Kerwin R.W. The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 2003, 28:1553-1561.
159. Parker K.J., Schatzberg A.F., Lyons D.M. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav 2003, 43:60-66.
160. Pego J.M., Morgado P., Pinto L.G., Cerqueira J.J., Almeida O.F., Sousa N. Dissociation of the morphological correlates of stress-induced anxiety and fear. Eur J Neurosci 2008, 27:1503-1516.
161. Perrot-Sinal T.S., Gregus A., Boudreau D., Kalynchuk L.E. Sex and repeated restraint stress interact to affect cat odor-induced defensive behavior in adult rats. Brain Res 2004, 1027:161-172.
162. Pesold C., Impagnatiello F., Pisu M.G., Uzunov D.P., Costa E., Guidotti A., et al. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci USA 1998, 95:3221-3226.
163. Pham K., Nacher J., Hof P.R., McEwen B.S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur J Neurosci 2003, 17:879-886.
164. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
165. Platt J.E., Stone E.A. Chronic restraint stress elicits a positive antidepressant response on the forced swim test. Eur J Pharmacol 1982, 82:179-181.
166. Porsolt R.D., Le P.M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
167. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978, 47:379-391.
168. Qiu S., Korwek K.M., Pratt-Davis A.R., Peters M., Bergman M.Y., Weeber E.J. Cognitive disruption and altered hippocampus synaptic function in reelin haploinsufficient mice. Neurobiol Learn Mem 2006, 85:228-242.
169. Regenthal R., Koch H., Kohler C., Preiss R., Krugel U. Depression-like deficits in rats improved by subchronic modafinil. Psychopharmacology (Berl) 2009, 204:627-639.
170. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 2006, 11:514-522.
171. Rodrigues S.M., LeDoux J.E., Sapolsky R.M. The influence of stress hormones on fear circuitry. Annu Rev Neurosci 2009, 32:289-313.
172. Rubin R.T., Phillips J.J., Sadow T.F., McCracken J.T. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 1995, 52:213-218.
173. Sachar E.J., Baron M. The biology of affective disorders. Annu Rev Neurosci 1979, 2:505-517.
174. Sahay A., Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci 2007, 10:1110-1115.
175. Sandi C., Merino J.J., Cordero M.I., Touyarot K., Venero C. Effects of chronic stress on contextual fear conditioning and the hippocampal expression of the neural cell adhesion molecule, its polysialylation, and L1. Neuroscience 2001, 102:329-339.
176. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000, 48:755-765.
177. Sapolsky R.M. Is impaired neurogenesis relevant to the affective symptoms of depression?. Biol Psychiatry 2004, 56:137-139.
178. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985, 5:1222-1227.
179. Schule C., Baghai T.C., Eser D., Rupprecht R. Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression. Expert Rev Neurother 2009, 9:1005-1019.
180. Scott B.W., Wojtowicz J.M., Burnham W.M. Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp Neurol 2000, 165:231-236.
181. Seib L.M., Wellman C.L. Daily injections alter spine density in rat medial prefrontal cortex. Neurosci Lett 2003, 337:29-32.
182. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008, 64:527-532.
183. Sheline Y.I. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 2000, 48:791-800.
184. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999, 19:5034-5043.
185. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003, 160:1516-1518.
186. Shepard J.D., Barron K.W., Myers D.A. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 2000, 861:288-295.
187. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003, 54:70-75.
188. Skorzewska A., Bidzinski A., Lehner M., Turzynska D., Wislowska-Stanek A., Sobolewska A., et al. The effects of acute and chronic administration of corticosterone on rat behavior in two models of fear responses, plasma corticosterone concentration, and c-Fos expression in the brain structures. Pharmacol Biochem Behav 2006, 85:522-534.
189. Soares J.C., Mann J.J. The functional neuroanatomy of mood disorders. J Psychiatr Res 1997, 31:393-432.
190. Sonino N., Fava G.A. Residual symptoms in depression an emerging therapeutic concept. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:763-770.
191. Sousa N., Madeira M.D., Paula-Barbosa M.M. Effects of corticosterone treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study. Brain Res 1998, 794:199-210.
192. Sousa N., Lukoyanov N.V., Madeira M.D., Almeida O.F., Paula-Barbosa M.M. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 2000, 97:253-266.
193. Southwick S.M., Vythilingam M., Charney D.S. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol 2005, 1:255-291.
194. Starkman M.N., Schteingart D.E., Schork M.A. Cushing's syndrome after treatment: changes in cortisol and ACTH levels, and amelioration of the depressive syndrome. Psychiatry Res 1986, 19:177-188.
195. Starkman M.N., Gebarski S.S., Berent S., Schteingart D.E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992, 32:756-765.
196. Starkman M.N., Giordani B., Gebarski S.S., Berent S., Schork M.A., Schteingart D.E. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 1999, 46:1595-1602.
197. Starkman M.N., Giordani B., Gebarski S.S., Schteingart D.E. Improvement in mood and ideation associated with increase in right caudate volume. J Affect Disord 2007, 101:139-147.
198. Stockmeier C.A., Mahajan G.J., Konick L.C., Overholser J.C., Jurjus G.J., Meltzer H.Y., et al. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 2004, 56:640-650.
199. Stone E.A., Lin Y. An anti-immobility effect of exogenous corticosterone in mice. Eur J Pharmacol 2008, 580:135-142.
200. Stone E.A., Egawa M., McEwen B.S. Novel effect of chronic corticosterone treatment on escape behavior in rats. Behav Neural Biol 1988, 50:120-125.
201. Surget A., Saxe M., Leman S., Ibarguen-Vargas Y., Chalon S., Griebel G., et al. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 2008, 64:293-301.
202. Tata D.A., Marciano V.A., Anderson B.J. Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J Comp Neurol 2006, 498:363-374.
203. Taylor Tavares J.V., Clark L., Cannon D.M., Erickson K., Drevets W.C., Sahakian B.J. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol Psychiatry 2007, 62:917-924.
204. Thompson B.L., Erickson K., Schulkin J., Rosen J.B. Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala. Behav Brain Res 2004, 149:209-215.
205. Trofimiuk E., Braszko J.J. Alleviation by Hypericum perforatum of the stress-induced impairment of spatial working memory in rats. Naunyn Schmiedebergs Arch Pharmacol 2008, 376:463-471.
206. van Praag H., Kempermann G., Gage F.H. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 1999, 2:266-270.
207. Vasterling J.J., Brailey K., Constans J.I., Sutker P.B. Attention and memory dysfunction in posttraumatic stress disorder. Neuropsychology 1998, 12:125-133.
208. Veena J., Srikumar B.N., Raju T.R., Shankaranarayana Rao B.S. Exposure to enriched environment restores the survival and differentiation of new born cells in the hippocampus and ameliorates depressive symptoms in chronically stressed rats. Neurosci Lett 2009, 455:178-182.
209. Veiel H.O. A preliminary profile of neuropsychological deficits associated with major depression. J Clin Exp Neuropsychol 1997, 19:587-603.
210. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci 2002, 22:6810-6818.
211. Vyas A., Bernal S., Chattarji S. Effects of chronic stress on dendritic arborization in the central and extended amygdala. Brain Res 2003, 965:290-294.
212. Walesiuk A., Braszko J.J. Gingkoselect alleviates chronic corticosterone-induced spatial memory deficits in rats. Fitoterapia 2009.
213. Walesiuk A., Trofimiuk E., Braszko J.J. Gingko biloba extract diminishes stress-induced memory deficits in rats. Pharmacol Rep 2005, 57:176-187.
214. Watanabe Y., Gould E., Daniels D.C., Cameron H., McEwen B.S. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 1992, 222:157-162.
215. Watanabe Y., Gould E., McEwen B.S. Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res 1992, 588:341-345.
216. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., et al. Reelin and ApoE receptors cooperate to enhance hippocampal syanptic plasticity and learning. J Biol Chem 2002, 277:39944-39952.
217. Wellman C.L. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol 2001, 49:245-253.
218. Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 1984, 83:1-16.
219. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 1997, 134:319-329.
220. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
221. Wong E.Y., Herbert J. The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus. Eur J Neurosci 2004, 20:2491-2498.
222. Wong E.Y., Herbert J. Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus. Neuroscience 2006, 137:83-92.
223. Wood G.E., Young L.T., Reagan L.P., McEwen B.S. Acute and chronic restraint stress alter the incidence of social conflict in male rats. Horm Behav 2003, 43:205-213.
224. Wood G.E., Norris E.H., Waters E., Stoldt J.T., McEwen B.S. Chronic immobilization stress alters aspects of emotionality and associative learning in the rat. Behav Neurosci 2008, 122:282-292.
225. Woolley C.S., Gould E., McEwen B.S. Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res 1990, 531:225-231.
226. Zakzanis K.K., Leach L., Kaplan E. On the nature and pattern of neurocognitive function in major depressive disorder. Neuropsychiatry Neuropsychol Behav Neurol 1998, 11:111-119.
227. Zhao C., Deng W., Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132:645-660.
228. Zhao Y., Ma R., Shen J., Su H., Xing D., Du L. A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 2008, 581:113-120.
229. Zhao Y., Shen J., Su H., Li B., Xing D., Du L. Chronic corticosterone injections induce a decrease of ATP levels and sustained activation of AMP-activated protein kinase in hippocampal tissues of male mice. Brain Res 2008, 1191:148-156.